We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$343M
AUM Growth
-$50.3M
Cap. Flow
-$56.3M
Cap. Flow %
-16.41%
Top 10 Hldgs %
78.35%
Holding
286
New
92
Increased
41
Reduced
68
Closed
66

Sector Composition

Rank Sector Weight
1 Real Estate 24.12%
2 Healthcare 12.62%
3 Financials 1.65%
4 Technology 1.41%
5 Industrials 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAS icon
251
Masco
MAS
$16B
-2,259
Closed -$125K
MCRB icon
252
Seres Therapeutics
MCRB
$48M
-8,275
Closed -$1.15M
LITS
253
Lite Strategy Inc
LITS
$33.6M
-4,150
Closed -$229K
MNST icon
254
Monster Beverage
MNST
$91.4B
-1,556
Closed -$69K
MRSN
255
DELISTED
Mersana Therapeutics
MRSN
-2,620
Closed -$618K
MUJ icon
256
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$640M
-10,018
Closed -$157K
NAD icon
257
Nuveen Quality Municipal Income Fund
NAD
$2.71B
-7,090
Closed -$111K
NEM icon
258
Newmont
NEM
$98.2B
-2,048
Closed -$111K
NNDM
259
Nano Dimension
NNDM
$309M
-100,000
Closed -$564K
NOVT icon
260
Novanta
NOVT
$5.04B
-7,500
Closed -$1.16M
PGR icon
261
Progressive
PGR
$124B
-1,391
Closed -$126K
PMT
262
PennyMac Mortgage Investment
PMT
$849M
-26,764
Closed -$527K
PMO
263
Franklin Municipal Opportunities Trust
PMO
$282M
-23,000
Closed -$315K
REGN icon
264
Regeneron Pharmaceuticals
REGN
$68.8B
-400
Closed -$242K
ROL icon
265
Rollins
ROL
$18.6B
-1,544
Closed -$55K
RVTY icon
266
Revvity
RVTY
$12.3B
-469
Closed -$81K
SNPS icon
267
Synopsys
SNPS
$71.5B
-5,000
Closed -$1.5M
STRO icon
268
Sutro Biopharma
STRO
$379M
-2,600
Closed -$491K
SYRE icon
269
Spyre Therapeutics
SYRE
$8.87B
-4,400
Closed -$875K
THD icon
270
iShares MSCI Thailand ETF
THD
$361M
-1,054
Closed -$79K
TMO icon
271
Thermo Fisher Scientific
TMO
$211B
-128
Closed -$73K
TYL icon
272
Tyler Technologies
TYL
$12.2B
-155
Closed -$71K
UNH icon
273
UnitedHealth
UNH
$382B
-402
Closed -$157K
VGM icon
274
Invesco Trust Investment Grade Municipals
VGM
$549M
-10,000
Closed -$137K
VNQI icon
275
Vanguard Global ex-US Real Estate ETF
VNQI
$3.46B
-4,038
Closed -$227K

Similar funds

AlphaCentric Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, AlphaCentric Advisors held 286 positions worth $343M, down 13% from $393M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

AlphaCentric Advisors withdrew a net $56.3M in Q4 2021, closing 66 positions and reducing 68 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $1.86M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, AlphaCentric Advisors opened a new position in Jazz Pharmaceuticals worth $1.27M.

  • AlphaCentric Advisors's largest Q4 2021 buy was Jazz Pharmaceuticals: 10,000 shares worth $1.27M.
  • AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2021, an estimated $1.84M increase.
  • AlphaCentric Advisors's biggest Q4 2021 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $30.4M.
  • AlphaCentric Advisors fully exited Vertex Pharmaceuticals in Q4 2021, selling an estimated $1.86M.
  • AlphaCentric Advisors's ten largest holdings make up 78% of its $343M portfolio in Q4 2021.
  • AlphaCentric Advisors opened 92 new positions and closed 66 in Q4 2021.
  • AlphaCentric Advisors's portfolio value fell 13% quarter-over-quarter to $343M.

Based on AlphaCentric Advisors's 13F filing for Q4 2021, filed 25 Feb 2022.